Top Congressional Buys Exceed 500 Percent From Disclosure

Congressional disclosure data has uncovered a set of purchases that produced remarkable gains after they were filed with the public. Leading the list are positions by Reps. Lisa McClain and Ro Khanna that delivered triple- and even octuple-digit returns since their respective disclosure dates.

For instance, Rep. Lisa McClain bought SNDK, an outlier we are still verifying, which has returned 864.86 percent since the disclosure on November 21, 2025. Rep. Ro Khanna purchased CCG, another outlier we are still verifying, posting 517.28 percent since its February 6, 2026 disclosure. The same member also bought MRNA, an outlier under verification, with a return of 513.49 percent from the January 6, 2026 disclosure date. Importantly, these returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed.

Verified transactions show similar strength. Lisa McClain's CIEN purchase, disclosed August 13, 2025, has gained 373.09 percent. Rep. Tim Moore's TZA buy from the July 9, 2025 disclosure carries a 316.91 percent return. Rep. Scott H. Peters bought KSS with disclosure on May 16, 2025 for a 258.77 percent gain to date. These performances span technology, healthcare, consumer cyclical, communication services and leveraged inverse strategies.

The timing of several of these buys relative to subsequent price moves raises questions, particularly in the technology sector where both SNDK and CIEN delivered triple-digit gains after filing. With holding periods ranging from 288 to 643 days, the data suggests some alignment with longer-term sector shifts rather than brief trades. While past results do not predict future performance, tracking such public filings offers retail investors one lens into how lawmakers deploy capital across sectors.

This is data analysis, not financial advice.